Sanofi Pasteur Articles
US FDA fast-track for Sanofi Pasteur's KB001A; orphan status for Teva/Xenon's XEN402; second BD Simplist product approved
23 April 2013
Sanofi eyes big plans for China
11 February 2013
News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102
17 December 2012
Australian launch for Sanofi Pasteur's Imojev, first single-dose vaccine against Japanese encephalitis
11 December 2012
CREW files motion to quash Sanofi Pasteur subpoena
6 December 2012
Clinical trial results indicate advance in Dengue vaccine research by Sanofi Pasteur
12 September 2012
Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations
25 July 2012
EMA backs approval of Revestive, Zinforo and Seebri Breezhaler, but not Elelyso; Hexaxim opinion
25 June 2012
US consumer groups call on FTC to investigate anti-competitive practices of vaccine makers
21 March 2012
Sanofi Pasteur and Vivalis extend MAb accord
19 January 2012
Sanofi Pasteur and CureVac collaborate on a $33.1 million project on vaccines for infectious diseases
16 November 2011
Merck KGaA replaces Schnee; Sanofi-Aventis makes senior executive change and extends Genzyme tender offer
13 December 2010
US FDA to fast-track Sanofi Pasteur's investigational Clostridium difficile vaccine
11 November 2010
Positive vaccine trial results from Novartis, Sanofi Pasteur and LigoCyte presented at IDSA meeting
26 October 2010
Sanofi-Aventis to cut 25% of workforce in US pharmaceutical operations as it faces a slew of patent expiries; signs vaccine preparedness deal
11 October 2010
Regulatory briefs: Shire’s Vpriv cleared in Europe; Menactra for toddlers; Updates for Novartis and Roche
27 August 2010
Draft guidance from UK’s NICE recommends Celgene and Janssen Cilag multiple myeloma drugs; Sanofi-Aventis’ Multaq approved for AF
27 August 2010
Showing 1-41 of 41 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
